Evidence map›Paper›PMID 40510424›Full record

ReviewFrontiers in pharmacology2025

Clinical application, potential pharmacological targets and quality marker prediction of a TCM formulation used (Shenling Baizhu San) in the treatment of respiratory diseases.

Zu Gao, Tong Wang, Liwen Fu, Qiaolan Wu, Yuan Wang, Zhichun Wu, Guangying Lu, Chunxue Ou, Haijun Zhao, Huayun Yu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zu Gao *College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Tong Wang *College of Nursing, Shandong University of Traditional Chinese Medicine, Jinan, China.
Liwen FuInnovative institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China.
Qiaolan WuCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Yuan WangCollege of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Zhichun WuCollege of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Guangying LuCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Chunxue OuCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Haijun ZhaoCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Huayun YuCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shenling Baizhu San (SLBZS) is a formulation of traditional Chinese medicine (TCM) recorded in the Song Dynasty medical book

Indexed as

clinical applicationpharmacological mechanismsquality markersrespiratory diseasesShenling Baizhu San

Identifiers

PMID40510424
PMCPMC12158943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.